Health Trak Plus Menthol-Infused Pain Relief Socks

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with simple aches, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to clean and dry the affected area prior to application. The socks should be removed from their packaging and placed on the feet, ensuring proper fit and coverage of the affected area.

The maximum duration of wear is 8 hours per day; patients must remove the socks after this period. It is recommended that the socks be washed separately from other clothing to maintain their integrity and effectiveness. Patients should wear the socks daily, but no more than 4 times per week to ensure optimal results and prevent skin irritation.

Contraindications

Use of this product is contraindicated in the following situations:

• Patients with a known allergy to any ingredients of this product or to chilli peppers should consult a physician prior to use.

• Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse reactions.

• Concurrent use with other external analgesic products is contraindicated to avoid compounded effects and increased risk of side effects.

• The use of a heating pad in conjunction with this product is not recommended, as it may enhance absorption and lead to increased risk of adverse effects.

Additionally, this product should not be applied immediately before or after activities such as swimming, showering, sunbathing, or intense exercise, as these actions may exacerbate skin irritation. Contact with eyes, mucous membranes, or rashes should be strictly avoided to prevent further complications.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with known allergies to any of its ingredients, including chilli peppers. Patients should be advised to consult a healthcare professional prior to use if they have such allergies.

The product should not be applied to wounds or damaged skin, nor should it be used concurrently with other external analgesic products. Additionally, the application of this product in conjunction with a heating pad is not recommended due to the potential for increased skin irritation or adverse effects.

Patients are instructed to discontinue use and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Furthermore, if any rash, itching, or excessive skin irritation occurs, medical consultation is warranted.

It is imperative to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be established without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated in individuals with known allergies to any ingredients, including chilli peppers, and those with wounds or damaged skin. The product should not be used concurrently with other external analgesic products or in conjunction with a heating pad.

During use, patients are advised against applying the product immediately before or after activities such as swimming, showering, sunbathing, or engaging in intense exercise. It is crucial to use the product only as directed and to avoid contact with the eyes, mucous membranes, or any rashes.

Patients should discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, if a rash, itching, or excessive skin irritation develops, medical advice should be sought.

For pregnant or breastfeeding individuals, it is recommended to consult a healthcare professional prior to use. The product should be kept out of reach of children, and in the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is necessary.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Health Trak Plus Menthol-Infused Pain Relief Socks (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring, or safety considerations for individuals with reduced kidney function. Healthcare professionals should exercise caution when prescribing this medication to patients with renal impairment, as the lack of data may impact treatment outcomes.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients about the potential for allergic reactions; they should be instructed to consult a doctor before use if they are allergic to any ingredients in the product or to chili peppers.

Patients should be cautioned against applying the product on wounds or damaged skin, and they should not use it concurrently with other external analgesic products or in conjunction with a heating pad. Providers should emphasize the importance of stopping use and consulting a doctor if the patient's condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, patients should be advised to discontinue use and seek medical advice if they experience rash, itching, or excessive skin irritation.

Patients should be instructed not to use the product immediately before or after engaging in activities such as swimming, showering, sunbathing, or intense exercise. It is crucial to remind patients to use the product only as directed and to avoid contact with eyes, mucous membranes, or rashes.

Storage and Handling

The product is supplied in various packaging configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, away from direct sunlight to maintain its integrity. Additionally, the product must be protected from excessive moisture to ensure optimal quality and efficacy. Proper handling and storage conditions are crucial for preserving the product's effectiveness.

Additional Clinical Information

The product is administered topically, with a maximum usage of 8 hours per day. Patients are advised to remove socks after this duration and to wear socks daily, but not more than four times per week.

Clinicians should counsel patients to consult a healthcare professional if they are pregnant or breastfeeding before using the product. Additionally, patients should discontinue use and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if they experience a rash, itching, or excessive skin irritation.

Drug Information (PDF)

This file contains official product information for Health Trak Plus Menthol-Infused Pain Relief Socks, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)